This announcement is a separate document:
联环药业：联环药业2024年度以简易程序向特定对象发行股票募集资金使用可行性分析报告
Jiangsu Lianhuan Pharmaceutical: Feasibility analysis report for the use of funds raised through the issuance of stocks to specific objects in easy procedures by Jiangsu Lianhuan Pharmaceutical in 2024.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.